TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DRIO

DarioHealth Corp

Healthcare · Health Information Services

6.50$ +4.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

DarioHealth Corp (DRIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 97 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DRIO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
6.7 3.9 6.0 6.7 9.5 7.0 9.8 8.1 14 14 11 12 8.6 25 20 17 41 35 124 131 117 101 127 137 126 119 108 117 107 96 137 122 110 119 116 108 118 110 103 97
5.6 2.9 5.1 5.9 8.6 6.0 8.9 7.3 14 13 9.9 11 7.2 23 18 16 40 34 88 72 59 46 71 82 72 66 55 66 56 47 53 39 30 41 39 32 42 35 28 22
3.3 1.1 2.8 3.9 6.3 3.7 7.0 5.0 11 11 7.0 8.0 4.6 21 16 13 37 29 81 64 52 36 56 68 57 49 39 53 44 37 34 23 16 28 28 22 32 26 20 6.6
3.6 1.3 3.1 4.1 6.5 4.0 7.2 5.2 12 11 7.0 8.0 4.6 21 16 13 37 29 81 64 52 36 56 68 57 49 43 53 44 37 34 23 16 28 28 22 32 26 20 14
0.9 0.3 1.2 1.0 1.2 0.4 0.8 0.9 0.9 0.2 0.8 0.8 0.9 0.7 0.8 0.6 1.2 1.7 0.5 2.9 2.1 1.8 7.8 6.0 6.6 6.4 5.3 4.8 6.5 3.6 7.9 10 8.4 5.4 5.9 5.4 2.4 2.7 2.2 1.5
1.1 0.9 0.8 0.7 0.9 1.2 0.9 1.2 1.0 1.4 1.9 1.8 1.5 1.4 1.2 1.3 1.6 2.3 5.0 4.6 4.1 6.2 7.8 8.3 7.8 8.0 6.9 5.9 5.5 5.1 4.9 5.1 4.7 4.8 4.6 4.6 4.9 4.3 4.2 3.7
1.1 0.9 0.9 0.8 0.8 0.9 0.8 0.8 0.8 0.7 1.5 1.5 1.4 1.4 1.3 1.2 0.6 0.6 0.7 1.1 0.7 0.7 0.7 0.8 0.9 0.8 0.8 0.8 – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – 25 39 39 42 42 42 42 42 42 42 42 42 57 57 57 57 57 57 57 57 57 57
– – – – – – – – – – – – – – – – – – 9.2 19 17 12 13 12 11 9.9 8.8 7.7 6.5 5.4 24 22 20 19 18 17 16 16 15 15
2.3 10 2.8 2.8 3.3 3.0 2.4 3.9 3.9 5.2 7.6 6.2 4.7 5.7 4.6 5.0 6.1 7.3 12 13 13 15 13 38 37 39 36 39 38 38 59 54 51 47 42 44 43 42 41 42
2.0 2.9 2.7 2.8 3.3 3.0 2.4 3.9 3.9 5.2 7.0 5.7 4.2 5.2 4.2 4.7 5.9 7.0 12 13 13 14 13 13 12 19 18 8.1 8.1 12 18 17 19 17 19 9.8 9.3 9.3 9.4 9.6
– – – – 1.4 – – – – – 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.1 0.3 9.1 8.9 0.1 0.1 4.1 4.9 6.1 9.3 6.0 11 0.5 0.4 0.4 0.4 0.6
0.0 1.8 1.5 1.0 2.0 1.9 1.1 0.3 2.2 2.6 3.0 2.4 1.4 1.7 1.2 1.6 2.0 2.5 3.4 4.0 4.0 5.1 4.2 3.3 2.0 2.3 1.9 1.5 1.9 1.1 4.2 3.4 2.7 3.0 2.7 3.4 3.5 2.9 3.5 3.2
– – – – – – – – – – 0.6 – – – – – – – – – – – – 23 24 18 17 29 29 25 25 23 20 23 19 30 31 31 31 31
4.4 -6.5 3.2 4.0 6.1 3.9 7.4 4.2 10 8.9 3.9 6.1 3.9 19 15 12 35 28 112 118 104 86 114 100 89 80 72 78 68 58 78 68 59 72 74 64 75 68 62 55
-50 -55 -52 -56 -59 -71 -74 -80 -84 -89 -95 -100 -103 -110 -121 -126 -134 -143 -159 -177 -200 -222 -238 -257 -273 -286 -299 -317 -334 -349 -359 -363 -378 -390 -404 -423 -442 -452 -460 -468
0.3 0.4 0.4 0.5 0.5 0.7 0.7 1.0 1.2 1.8 1.8 2.1 2.5 3.1 3.1 4.1 7.3 7.3 14 15 16 16 20 22 23 26 28 28 29 27 34 40 40 40 45 50 50 50 50 9.3

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?